Business Context and Reporting Period
The filing is a Form 10-Q for Colfax Corporation, not Enovis CORP, for the quarter and nine months ended September 27, 2013. Colfax was a diversified global industrial manufacturer providing gas- and fluid-handling and fabrication-technology products under the Howden, ESAB and Colfax Fluid Handling brands. Results were unaudited and prepared under U.S. GAAP.
Key Financial Metrics
| Metric | Three Months Ended September 27, 2013 | Comparable 2012 Period | Nine Months Ended September 27, 2013 | Comparable 2012 Period |
|---|---|---|---|---|
| Net sales | $1,014.6 million | $954.4 million | $3,035.8 million | $2,886.5 million |
| Gross profit / margin | $320.3 million / 31.6% | $288.0 million / 30.2% | $948.8 million / 31.3% | $844.6 million / 29.3% |
| Operating income | $102.8 million | $51.7 million | $286.8 million | $87.8 million |
| Net income attributable to Colfax | $55.5 million | $9.1 million | $141.5 million | $(84.1) million |
| Net income available to common shareholders | $50.4 million | $4.0 million | $126.2 million | $(98.0) million |
| Diluted earnings per share | $0.48 | $0.04 | $1.23 | $(1.09) |
- Net sales increased 6.3% year over year in both the quarter and nine-month period. Nine-month growth included $180.2 million from acquisitions, partly offset by $33.3 million of unfavorable foreign-currency translation.
- Nine-month operating income benefited from lower acquisition-related costs, restructuring charges and acquisition-related amortization compared with 2012.
- Net cash provided by operating activities was $186.8 million for the first nine months, versus $9.3 million in 2012.
- Capital expenditures were $50.9 million and acquisition spending was $13.7 million, producing $64.6 million of net investing cash outflow.
- Cash and cash equivalents were $639.3 million at September 27, 2013, up from $482.4 million at December 31, 2012. Approximately $343.0 million was held outside the United States and could be subject to repatriation restrictions or tax costs.
- Total debt was $1.52 billion, down from $1.73 billion at year-end 2012. Current debt was $131.7 million and long-term debt was $1.39 billion.
- The company reported $499.9 million available under revolving credit subfacilities and was in compliance with its debt covenants. The weighted-average borrowing rate under the amended credit agreement was 2.61%, excluding original-issue-discount accretion.
- Operating cash flow was affected by $27.1 million of net asbestos-related cash outflows and $37.0 million of defined-benefit-plan contributions during the nine-month period.
Segment Performance and Material Changes
- Gas and Fluid Handling: Quarterly sales increased to $511.4 million from $464.9 million, while nine-month sales increased to $1.45 billion from $1.39 billion. Segment operating margin improved to 13.2% for the quarter and 12.3% for the nine months, compared with 7.3% and 7.1%, respectively, primarily due to higher volume, cost controls and lower acquisition-related amortization.
- Fabrication Technology: Quarterly sales increased to $503.2 million from $489.6 million, and nine-month sales increased to $1.58 billion from $1.50 billion, largely due to acquisitions. Segment operating margin improved to 11.4% for the quarter and 10.2% for the nine months, compared with 9.0% and 7.1%, respectively. Benefits included manufacturing-site closures and improved margins at Soldex, partly offset by weaker existing-business consumable volumes.
- Company gross margin increased by 140 basis points in the quarter and 200 basis points for the nine-month period. The 2012 comparison included acquisition-related inventory step-up expense.
- SG&A declined to 20.5% of sales in the quarter and 21.1% for the nine-month period, versus 22.7% and 22.9% in 2012. Nine-month 2012 results included $43.6 million of Charter acquisition-related expense.
- Interest expense declined to $17.5 million in the quarter and $58.9 million for the nine months, versus $23.6 million and $68.3 million, respectively, due primarily to lower borrowing rates and debt balances. The 2013 period included approximately $3.1 million of refinancing-related charges.
- The company issued 7.5 million common shares in May 2013 for gross proceeds of approximately $331.9 million and net proceeds of approximately $319.9 million.
Guidance, Outlook, Risks and Unusual Items
- No explicit full-year earnings or revenue guidance is provided in the filing text. Management stated that the company expected its liquidity sources to fund operations for the next twelve months.
- Management expected approximately $20 million of additional restructuring and related charges during the remainder of 2013.
- Colfax entered into an irrevocable commitment to acquire the global infrastructure and industry division of Fläkt Woods Group for approximately €193 million, including assumed debt, subject to adjustments and regulatory approvals. Closing was expected in the fourth quarter of 2013.
- The company completed acquisitions of Clarus Fluid Intelligence for $14.3 million and additional Soldex shares for $14.9 million. Clarus included an estimated contingent payment of $3.6 million; the total contingent-payment liability was $7.0 million at quarter-end.
- Asbestos claims remained material: 22,946 unresolved claims were reported at September 27, 2013. The company recorded a $0.6 million net pre-tax asbestos-related charge, with gross liability increases partly offset by higher expected insurance recoveries. Actual liabilities and recoveries could differ materially from estimates.
- Venezuela’s currency devaluation and application of highly inflationary accounting resulted in a $2.9 million foreign-currency transaction loss during the nine months. Venezuela represented less than 1% of consolidated assets and sales.
- Approximately 81% of quarterly sales and 80% of nine-month sales were generated outside the United States, creating significant foreign-exchange exposure. A hypothetical 10% depreciation in major currencies would have reduced equity by approximately $150 million, net of hedging effects.
- A 1 percentage-point increase in interest rates would have increased interest expense by approximately $4.2 million for the quarter and $12.5 million for the nine-month period.
- Other principal risks included cyclical end markets, acquisition integration, restructuring execution, debt covenant restrictions, pension funding, product liability, raw-material costs, international operations, cybersecurity, tax matters and potential impairment of goodwill or intangible assets.
Important Facts for Investors to Verify
- Confirm the entity identity: the supplied filing is for Colfax Corporation, while the request metadata identifies Enovis CORP.
- Assess the sustainability of margin expansion after excluding acquisition-related amortization, inventory step-up effects, restructuring charges and other unusual items.
- Review the Fläkt Woods acquisition commitment, funding requirements, approval status and integration risks.
- Reconcile debt maturities, variable-rate exposure, covenant headroom and available revolving-credit capacity.
- Evaluate asbestos claim trends, insurance recoverability, insurer solvency and the sensitivity of recorded reserves to settlement assumptions.
- Consider the effect of foreign-currency movements, restricted offshore cash and Venezuela-related risks on future earnings and liquidity.
- Review acquisition contribution versus organic growth, particularly the weakness in existing fabrication-technology sales and gas-and-fluid-handling orders for certain end markets.